Evofem Biosciences Inc(EVFM) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Current Price

$1.22

RSI

14.299

Beta:

-0.475009

March 04, 2021
77.6M
-40.5M

60.432 %
-219.226 %
-99.611 %

$446,000
$0
$0
$0
$0
$0
100.000 %
%
%
%
0.000 %

$-142,305,000
$-80,029,000
$-125,710,000
$-9,993,451
$-13,018,598
$-43,157,045
-43.762 %
57.081 %
-92.050 %
30.271 %
231.503 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.